|
|
||||||||
Department of Zoology, Brigham Young University, Provo, Utah 84602
| |
ABSTRACT |
|---|
|
|
|---|
AMP-activated protein
kinase (AMPK) is activated during muscle contraction in response
to the increase in AMP and decrease in phosphocreatine (PCr).
Once activated, AMPK has been proposed to phosphorylate a number of
targets, resulting in increases in glucose transport, fatty acid
oxidation, and gene transcription. Although it has been possible to
directly observe phosphorylation of one of these targets, acetyl-CoA
carboxylase (ACC) in vitro, it has been more difficult to obtain direct
evidence of ACC phosphorylation in contracting skeletal muscle. In
these experiments using a phosphoserine antibody to ACC and a
phosphothreonine antibody to AMPK, evidence was obtained for
phosphorylation and activation of ACC in vitro, in gastrocnemius muscle
electrically stimulated at different frequencies, and in muscle from
rats running on the treadmill. Significant negative linear correlations
between phospho-ACC and ACC activity were observed in all models
(P < 0.01). The decline in ACC activity was related to
the decrease in PCr and the rise in AMP. A relationship between
phospho-AMPK (threonine 172) and activity of AMPK immunoprecipitated with anti-
2 subunit antibody preparation was also
observed. These data provide the first evidence of a direct link
between extent of phosphorylation of these proteins at sites recognized
by the antibodies and activity of the enzymes in electrically
stimulated muscle and in muscle of rats running on the treadmill.
creatine; fatty acid oxidation; malonyl-CoA; palmitoyl-carnitine transferase; phosphocreatine; AMP-activated protein kinase
| |
INTRODUCTION |
|---|
|
|
|---|
MALONYL-COENZYME A (CoA) inhibits carnitine palmitoyl-transferase 1 (CPT1), a rate-limiting enzyme of fatty acid oxidation, in skeletal muscle, heart, and liver (16, 22-26, 41, 42, 50, 52). Studies in rats demonstrate that a decrease in malonyl-CoA in muscle in response to contraction removes inhibition of CPT1 and allows fatty acid oxidation to increase to meet the increased energy requirement of the working muscle (24-28, 50-54). Evidence has been presented indicating that glycerol-3-phosphate acyltransferase is phosphorylated by AMP-activated protein kinase (AMPK), resulting in inactivation and shunting of fatty acids toward oxidation and away from the triacylglycerol synthesis pathway in muscle (30). The activity of acetyl-CoA carboxylase, the citrate-activated enzyme that synthesizes malonyl-CoA, decreases in muscle during exercise or in response to muscle contraction (7, 20, 37-40, 50, 52). Purified muscle acetyl-CoA carboxylase can be phosphorylated in vitro by AMP-activated protein kinase, with a consequent decrease in activity of the enzyme (53). The citrate activation curve is shifted to the right, resulting in a marked decrease in activity in the physiological range of citrate concentrations (53). These same changes in kinetic properties of ACC are observed in muscle during exercise (20, 37, 38, 46, 53).
Abundant data are now available indicating that AMPK is activated in
response to muscle contraction (8, 11, 20, 31, 37, 38, 46,
50-53, 57). Once activated, AMPK has been proposed to
phosphorylate a number of targets in muscle involved in ATP production,
resulting in increases in glucose transport, fatty acid oxidation, and
gene transcription (16, 29, 39, 50, 52). AMPK is a
heterotrimeric protein kinase that is activated by increases in muscle
AMP, an allosteric activator, and by decreases in muscle
phosphocreatine (PCr), an allosteric inhibitor (3, 5, 6, 16, 21,
36, 47). Studies have also demonstrated that AMPK can be
phosphorylated on threonine 172 of the
-subunit, resulting in
activation (6, 14, 16, 18, 43). Until recently, it was not
possible, however, to obtain a direct quantitation of the extent of
phosphorylation of muscle ACC by AMPK in exercising or electrically
stimulated muscle. Phosphoserine antibodies are now available for
assessing specific phosphorylation of skeletal muscle acetyl-CoA
carboxylase (ACC) at the activity-modulating AMPK target site (the site
equivalent to serine 79 of liver ACC). In addition, phosphothreonine
antibodies are available for quantitation of phosphorylation of
threonine 172 of the
-subunit of AMPK by the upstream kinase, AMPK
kinase. Interesting data have already been reported indicating
phosphorylation of ACC in contracting muscle of exercising human
subjects (4, 44). The importance of study of regulation of
ACC in muscle was recently highlighted in a report indicating that
knockout mice lacking the muscle isoform of ACC show less fat
accumulation than do normal mice and higher rates of fatty acid
oxidation in isolated muscle compared with those of control mice
(1). It has also been suggested that dysregulation of
fatty acid oxidation could contribute to development of insulin
insensitivity and Type 2 diabetes (24). Relatively little
information is available regarding the relationships among AMPK
activity, ACC activity, and the extent of phosphorylation of these
proteins. In the present studies, a wide range of phosphorylation states were generated by using purified AMPK and ACC, by using electrically stimulated muscle, and by using muscle from rats run on
the treadmill, allowing correlation of phosphorylation state with
activities of muscle ACC and AMPK.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
In vitro phosphorylation of purified ACC by AMPK. ACC was isolated from quadriceps and gastrocnemius muscles of the rat hindlimb as described previously (53). AMPK isolated from rat liver to the gel filtration step was obtained from the laboratory of Dr. Grahame Hardie (Dundee, Scotland) (3). For in vitro phosphorylation studies, ACC was precipitated in the presence of globulin-free albumin as described previously (53, 55). Final concentrations in the reaction mix were 34 mM HEPES, 68 mM NaCl, 0.68 mM EDTA, 0.68 mM EGTA, 0.68 mM dithiothreitol, 6.8% glycerol, 0.2 mM AMP, and 0.12 mM ATP, pH 7.0. Purified ACC was incubated for 30 min in the absence of kinase or in the presence of 5 U/ml AMPK or 6 U/ml cAMP-dependent protein kinase (PKA; Sigma Chemical). Aliquots of the mixture were added to Laemmli's buffer (1 vol reaction mixture:2 vol water:1 vol Laemmli's buffer) for PAGE with the Bio-Rad Mini-Protean II dual slab vertical electrophoresis system using Mini-Protean II 5% precast gels (Bio-Rad, Richmond, CA). Gels were run in the presence of 0.1% SDS, 25 mM Tris, and 192 mM glycine, pH 8.3, at 200 V for 45 min. Proteins were transferred by electroblotting from the gel to nitrocellulose membrane at 100 V for 50 min. Membranes were blocked in 5% nonfat dried milk (Bio-Rad) in PBST (139 mM NaCl, 2.7 mM KH2PO4, 9.9 mM Na2HPO4, and 0.1% Tween 20) and were then left overnight with immunoaffinity-purified rabbit anti-phospho-ACC antibody (Immunogen = synthetic peptide corresponding to amino acids 73-85 of rat ACC, CHMRSSM[pS] GLHLVK, conjugated to keyhole limpet hemocyanin; Upstate Biotechnology, Waltham, MA) at a dilution of 1:2,000. The next day, membranes were washed twice in PBST and twice in PBS (139 mM NaCl, 2.7 mM KH2PO4, 9.9 mM Na2HPO4). Membranes were then exposed to horseradish peroxidase-conjugated donkey anti-rabbit IgG (Amersham Biosciences, Piscataway, NJ) for 1 h at room temperature followed by washing twice in PBST and twice in PBS. The phosphorylated ACC spots were then visualized on enhanced chemiluminescence hyperfilm (Amersham Biosciences). Relative amounts of phospho-ACC were quantified by use of a Hewlett-Packard Scan Jet 6200C and SigmaGel software (SPSS, Chicago, IL). In a time course experiment, ACC activity was measured as described previously (53) at 0.5 mM citrate on aliquots removed from the phosphorylation reaction mixture at intervals after addition of the AMPK. At the same time intervals, aliquots were removed and added to the Laemmli's buffer mixture and frozen in liquid nitrogen. These samples were later analyzed for ACC phosphorylation by the Western blotting procedure described above. This allowed generation of a wide range of ACC activities and of ACC phosphorylation states. Samples from all time points were run on the same gel and blot. After densitometric scanning and quantitation, intensities of all spots were expressed relative to the darkest phospho-ACC spot on the blot. The ACC activities and phosphorylation states were then subjected to correlation analysis and linear regression by use of the Number Cruncher Statistical Software (NCSS, Kaysville, UT).
In situ stimulation of the gastrocnemius muscle.
Male Sprague-Dawley strain rats (Sasco, Wilmington, MA) were housed in
single cages in a room lighted between 6 AM and 6 PM. Rats were
provided with water and Harlan Teklad rat chow ad libitum until the
time of killing. All procedures involving use of rats were approved by
the Institutional Animal Care and Use Committee at Brigham Young
University. On the day of the experiment, rats (age ~2 mo, body
wt = 238 ± 6 g) were anesthetized with pentobarbital sodium (50 mg/kg body wt ip). They were kept anesthetized at a surgical
level by injection of additional anesthetic for at least 45 min before
surgery. The purpose of this delay was to allow any increase in AMPK
due to the handling procedure to return to baseline values before the
beginning of the experiment. The tibial nerve was then exposed by blunt
dissection. Gastrocnemius muscles were collected at rest or after
stimulation via the tibial nerve with single pulses of 10 ms duration
and 10 V for 5 min at frequencies of 0.2, 1, and 5 s
1.
The purpose of this procedure was to generate conditions of a broad
spectrum of AMPK activities, phosphorylated ACC, and ACC activities. At
the end of the stimulation, the gastrocnemius was clamp frozen between
stainless steel clamps at liquid nitrogen temperature and then stored
at
90°C until analyzed.
-mercaptoethanol, pH 7.5, and proteolytic enzyme inhibitors (8 trypsin inactivating units/l aprotinin, 1 mg/l leupeptin, and 1 mg/l
antitrypsin). After centrifugation at 48,000 g for 30 min,
the supernatant was analyzed for phospho-ACC by Western blotting as
described above. ACC for citrate-dependent activity was isolated from
this homogenate as described previously. ACC activity was determined at
citrate concentrations ranging from 0 to 20 mM as described previously (53). The Grafit program (Sigma Chemical) was used for
analyzing the data to obtain the citrate activation constant
(Ka) and maximal activity as a function of
citrate (Vmax). A second homogenate (1:9) was
also prepared in 50 mM Tris · HCl, 250 mM mannitol, 50 mM NaF,
5 mM sodium pyrophosphate, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, pH
7.4, and proteolytic enzyme inhibitors (1 mM benzamidine, 0.1 mM
phenylmethane sulfonyl fluoride, and 5 µg/ml soybean trypsin
inhibitor). The Western blot for phospho-AMPK was performed on the
700-g supernatant of this homogenate. The immunoaffinity-purified phospho-AMPK primary antibody (Immunogen = synthetic phospho-threonine peptide corresponding to residues surrounding threonine 172, SDGEFLR[pT]SCGSPNY, of the
-subunit of
human AMPK conjugated to keyhole limpet hemocyanin) was obtained from
Cell Signaling Technology (Beverly, MA). The dilution for the Western
blot was 1:1,000. Samples from each stimulation frequency were run on
the same gel and blot. After densitometric scanning and quantitation,
intensities of all spots were expressed relative to the darkest spot on
the blot.
The
1 and
2 AMPK activities were
determined on immunoprecipitates by using commercially prepared
(Affinity Bioreagents, Goldon, CO) affinity-purified antibodies to the
peptides TSPPDSFLDDHHLTR (
1) and MDDSAMHIPPGLKPH
(
2) conjugated to keyhole limpet hemocyanin at the
NH2 terminus via a cysteine residue. The
immunoprecipitation and AMPK activity measurements were done by methods
described by Hardie et al. (17), with the exceptions that
the immunoprecipitation was overnight and the AMPK assay was on
resuspended immunoprecipitate in the medium described previously
(53).
A perchloric acid extract (100 mg powder/ml 6% perchloric acid) was
also made of the frozen muscle powder for determination of creatine
(48), PCr (19), ATP (19),
lactate (12), and estimated free AMP (9).
Glycogen was determined by the method of Passonneau and Lowry
(35).
Effect of treadmill running on phospho-ACC in different types of muscle. Rats were run on a rodent treadmill for 5-10 min a day for 1 wk at speeds ranging from 15 to 31 m/min to accustom them to treadmill running. A jugular catheter was installed 3 days before the day of killing. On the day of the experiment, rats (age ~2 mo, body wt = 245 ± 2 g) were killed at rest or after 10 min of running at 16 m/min or after 5 min at 16 m/min + 5 min at 31 m/min up a 15% grade. They were rapidly anesthetized via the jugular catheter (35 mg pentobarbital sodium/kg body wt) at the end of the run. With intravenous administration of the anesthetic, rats are anesthetized immediately, allowing removal of the muscles in time to preserve changes in ACC and AMPK, resulting from the exercise. Although it is possible that the anesthesia procedure could alter detected responses, it is clear from recovery studies that contraction-induced AMPK and ACC activity changes are preserved for several minutes into the postexercise period (37). Muscles were removed rapidly and frozen with use of stainless steel clamps at liquid nitrogen temperature. Phospho-ACC was determined by Western blot. ACC was partially purified by use of ammonium sulfate precipitation, and activity was determined as described previously (53). This allowed correlation of phospho-ACC with ACC activity. Total AMPK activity was also determined on this resuspended ammonium sulfate precipitate (53). This method results in lower activities than the immunoprecipitation method and it does not distinguish the different isoforms, but has been used extensively to characterize this signaling system. It is not clear whether the difference in magnitude of activities between the two approaches is a result of a difference in yield or of a difference in incubation conditions.
Statistical analyses. Linear regression, correlation analysis, and analysis of variance followed by Fisher's least significant differences tests were run by use of the Number Cruncher Statistical Software. Where appropriate, 95% confidence intervals are shown on the graphs. A probability value of 0.05 was used for all analyses for determination of statistically significant changes in response to treatments.
| |
RESULTS |
|---|
|
|
|---|
In vitro phosphorylation of muscle ACC by AMPK.
Figure 1 demonstrates that the
phospho-ACC antibody reacts with AMPK-phosphorylated ACC but not to any
great extent with the nonphosphorylated ACC isolated from skeletal
muscle. It also demonstrates that the phosphorylation is specific for
the AMPK site in that phosphorylation by PKA (previously shown to
phosphorylate the muscle isoform of ACC) does not result in an increase
in immunoreactivity as detected by the Western blot using the
phospho-ACC antibody. Figure 2,
top, shows the time course of the increase in
phosphorylation of ACC along with the decrease in ACC activity at 0.5 mM citrate. Figure 2, bottom, demonstrates the correlation
(with 95% confidence intervals) and linear regression between ACC
phosphorylation and ACC activity.
|
|
In situ stimulation of the gastrocnemius muscle.
Figure 3 demonstrates the effect of
different rates of stimulation (5 min) on glycogen, lactate, adenine
nucleotides, PCr, creatine, AMPK (
2-isoform) activity,
and ACC activity at 0.5 mM citrate. As can be seen from the figure,
with the exceptions of PCr and ACC activity, no marked changes occurred
at the lowest stimulation rate (0.2 s
1). Higher
stimulation rates were accompanied by significant declines in glycogen,
ATP, and PCr and significant increases in lactate, creatine, estimated
free AMP, and
2 AMPK activity. The decline in ACC
activity at 0.5 mM citrate appeared to occur beginning at a stimulation
rate of 0.2 s
1, yet AMPK activity was significantly
increased only at higher stimulation rates (1 and 5 s
1).
When the relationships are examined as a function of stimulation rate,
the decrease in ACC activity at 0.5 mM citrate appeared to correlate
better with the decline in PCr than with the increase in AMPK activity
(i.e., due to phosphorylation). The
1- isoform AMPK
activity showed a similar pattern to
2 but with a
smaller magnitude of change in response to stimulation. Values were
0.72 ± 0.09 for resting muscle and 1.33 ± 0.32, 1.49 ± 0.27, and 1.71 ± 0.25 nmol · g
1 · min
1 for
muscles stimulated at frequencies of 0.2, 1, and 5 s
1,
respectively (n = 5).
|
1 for both
Ka and Vmax compared with
resting values. At a stimulation rate of 0.2 s
1, only
Vmax was found to be significantly reduced
(P < 0.05), although there appeared to be a tendency
toward a higher Ka as well.
|
|
|
|
Effect of treadmill running on phospho-ACC in different types of
skeletal muscle.
Blood lactate was 1.4 ± 0.2 mM when rats were killed at rest,
2.1 ± 0.1 mM when rats ran at 16 m/min for 10 min, and 3.2 ± 0.3 mM when rats ran at 16 m/min for 5 min followed by 31 m/min for
5 additional minutes. The value in exercising rats was significantly different (P < 0.05) from that in resting rats only at
the highest work rate. Total AMPK activity (determined on resuspended
ammonium sulfate precipitates of muscle) for the red quadriceps was
found to be 0.13 ± 0.01, 0.19 ± 0.02, and 0.39 ± 0.04 nmol · g
1 · min
1 for
resting rats and rats run at 16 m/min and 31 m/min, respectively. For
soleus, corresponding values were 0.11 ± 0.01, 0.13 ± 0.01, and 0.18 ± 0.02 nmol · g
1 · min
1.
Differences were significantly different from resting values only at
the highest work rate (P < 0.05).
|
| |
DISCUSSION |
|---|
|
|
|---|
The principal liver isoform of ACC has been demonstrated to have
three sites that are phosphorylated by AMPK: serine 79, serine 1200, and serine 1215 (6, 14, 16, 21). It is phosphorylation of
ACC at serine 79 and serine 1200 that has been demonstrated to result
in a decline in liver ACC activity (6, 14, 16, 21). The
skeletal muscle isoform has not been completely characterized with
regard to phosphorylation sites for AMPK, but it is clear that it is a
larger protein (2, 15, 45, 49, 56). Although both skeletal
muscle and heart isoforms have been grouped together and called ACC
(or ACC2), it is not entirely certain that heart and skeletal muscle
ACC in the rat are identical. PKA has been demonstrated to
phosphorylate and inactivate rat heart and liver ACC (10, 16,
21). In liver ACC, serines 77 and 1200 can be phosphorylated by
PKA (6, 14, 21). It is clear that muscle ACC can be
phosphorylated by PKA, but with no detectable change in ACC activity
(55), thus indicating a distinct difference between heart
and muscle isoforms. Sequential in vitro phosphorylation studies with
PKA and AMPK demonstrate mutual interference, implying the existence of
at least one common site or of sites in close proximity that physically
interfere in muscle ACC (55). Despite the fact that prior
phosphorylation with PKA reduces [32P]phosphate
incorporation from ATP into ACC in response to AMPK treatment, the
inactivating effects of phosphorylation by AMPK are not enhanced or
prevented. Phosphorylation of the muscle ACC with PKA had no effect on
activity, regardless of the order of phosphorylation (55).
This would imply that it is a unique AMPK target site (probably
equivalent to serine 79 of the liver isoform) that is responsible for
activity modulation in muscle ACC and that the site equivalent to
serine 1200 in liver ACC is a silent site.
The antibody used to detect phospho-ACC in the present study was prepared against a phospho-peptide sequence surrounding serine 79 of the liver isoform. It is apparent, however, from the present studies, that this antibody also detects phosphorylation of the muscle isoform of ACC. ACC purified from skeletal muscle shows only a faint band in the Western blot for phospho-ACC, indicating that the isolation procedure produces primarily the nonphosphorylated ACC. A very dark band on the Western blot is seen after treatment of the purified ACC with AMPK, AMP, and ATP. No increase in phosphorylation is detected by the phospho-ACC antibody when purified muscle ACC is treated with PKA. Furthermore, in the present studies, a high degree of correlation is noted between ACC activity and phospho-ACC, providing evidence that it is phosphorylation at the site detected by the phospho-ACC antibody that is causing the decline in activity as seen in Figs. 2 and 5.
Previous in vitro studies using [32P]ATP have demonstrated phosphorylation of purified ACC by AMPK with concurrent decline in extent of citrate activation of ACC, particularly at low citrate concentrations (53). Declines in activity of ACC and changes in the kinetic constants, Ka and Vmax, similar to that induced by phosphorylation in vitro, were observed in muscle of rats running on the treadmill and in gastrocnemius muscles of rats electrically stimulated via the nerve (20, 37, 38, 46, 53). This provided strong evidence that ACC was being phosphorylated by AMPK in contracting muscles. It had not been possible, however, to directly observe phosphorylation of ACC in exercising or stimulated muscle until the specific phospho-ACC antibodies became available.
The first studies utilizing the phospho-ACC antibody were done on
muscle biopsies of human subjects. Exercise on the treadmill resulted
in marked increases in phosphorylation of ACC (4, 44).
Studies in exercising rats and in electrically stimulated rat hindlimb
muscles have demonstrated marked decreases in malonyl-CoA corresponding
to increases in AMPK activity and decreases in ACC activity (10,
37-39, 46, 50-53). Hindlimb perfusion studies using
5-aminoimidazole-4-carboxamide-1-
-D-ribofuranoside
to activate AMPK also show an inverse relationship between ACC activity
(and consequently malonyl-CoA concentration) and fatty acid oxidation (27, 28). Some evidence has been obtained for
phosphorylation and activation of malonyl-CoA decarboxylase by AMPK in
response to contraction, but purified and recombinant malonyl-CoA
decarboxylase does not appear to be a substrate for AMPK in vitro
(13, 40).
Studies in human subjects show very low concentrations of malonyl-CoA in resting muscle with little or no change during the course of exercise (7, 32-34). Despite these observations, which tend to discount the functioning of this control system in humans, the fact that AMPK is activated and ACC is phosphorylated in exercising human muscle emphasizes the possible importance of this pathway in regulation of fatty acid oxidation. It has been suggested that ACC may be localized near the mitochondrial outer membrane and that local production of malonyl-CoA in the environment of CPT1 may be more important in control of fatty acid oxidation than is the total muscle malonyl-CoA, which does not appear to fluctuate markedly in human muscle during exercise (24, 50).
The present studies on muscle stimulated in situ clearly demonstrate an
increase in phosphorylation state of ACC corresponding to a decrease in
ACC activity due to activation of AMPK. The measured increase in AMPK
activity also corresponds to an increase in phosphorylation of
threonine 172 of the
subunit of AMPK, detected by the phospho-AMPK antibody. In addition to the phosphorylation effect, the AMPK was
likely activated allosterically by the increase in free AMP in the
muscle and by the decline in the inhibitor, PCr. In fact the allosteric
effect may predominate at the lowest stimulation rate (0.2 s
1), because at that frequency a significant decline in
ACC activity and increase in phospho-ACC occurred in the absence of a
detectable change in AMPK activity or AMPK phosphorylation. A
significant decline in muscle content of PCr occurred at this
stimulation frequency. Furthermore, the relationship between PCr and
ACC activity showed a relatively high correlation coefficient
(R2 = 0.72).
The correlation between AMPK activity and ACC activity was relatively low (R2 = 0.39) compared with the correlation between PCr and ACC activity (R2 = 0.72). If ACC activity is considered to be a reporter for the activity of AMPK in the intact muscle, it is reasonable to assume that allosteric activation is responsible for the decline in ACC activity at the lowest stimulation rate. The allosteric activators (AMP) and inhibitors (PCr) would be expected to be discarded during the extensive washing associated with immunoprecipitation of the AMPK. AMP is then added to the reaction mix to maximally activate the enzyme. Only changes in activity due to phosphorylation are detected in this assay.
The absence of a change in ACC activity and phosphorylation in the white quadriceps is not surprising, considering the fact that the low-oxidative type IIb fibers are not likely recruited except at high work rates. Previous studies have demonstrated much smaller changes in glycogen content of the white quadriceps than in the red quadriceps and soleus during the course of treadmill exercise bouts (38, 51).
In summary, the increase in degree of phosphorylation of AMPK at a site
detected by an antibody directed against phosphothreonine 172 of the
-subunit is associated with corresponding increasing activity of
immunoprecipitated AMPK in contracting gastrocnemius muscle. The
increase in degree of phosphorylation of ACC at a site detected by an
antibody against serine 79 of liver ACC (the target site for AMPK)
correlates well with the decrease in activity of the ACC in three
models: purified ACC phosphorylated in vitro by purified AMPK, ACC
isolated from gastrocnemius muscles stimulated in situ, and ACC
isolated from red quadriceps and soleus muscles of rats running on the
treadmill. These studies provide additional information regarding the
important role of AMPK in controlling malonyl-CoA concentration and
hence fatty acid oxidation in skeletal muscle.
| |
ACKNOWLEDGEMENTS |
|---|
This work was supported by National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant AR-41438. Dr. D. G. Hardie provided the purified AMPK.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: W. W. Winder, 545 WIDB, Dept. of Zoology, Brigham Young Univ., Provo, UT 84602 (E-mail: william_winder{at}byu.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
10.1152/japplphysiol.00071.2002
Received 29 January 2002; accepted in final form 16 February 2002.
| |
REFERENCES |
|---|
|
|
|---|
1.
Abu-Elheiga, L,
Matzuk MM,
Abo-Heshema KA,
and
Wakil SJ.
Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2.
Science
291:
2558-2559,
2001
2.
Bianchi, A,
Evans JL,
Iverson AJ,
Nordlund A,
Watts TD,
and
Witters LA.
Identification of an isozymic form of acetyl-CoA carboxylase.
J Biol Chem
265:
1502-1509,
1990
3.
Carling, D,
Clarke PR,
Zammit VA,
and
Hardie DG.
Purification and characterization of the AMP-activated protein kinase.
Eur J Biochem
186:
129-136,
1989[ISI][Medline].
4.
Chen, ZP,
McConnell GK,
Michell BJ,
Snow RJ,
Canny BJ,
and
Kemp BE.
AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation.
Am J Physiol Endocrinol Metab
279:
E1202-E1206,
2000
5.
Davies, SP,
Carling D,
and
Hardie DG.
Tissue distribution of the AMP-activated protein kinase and lack of activation by cyclic-AMP-dependent protein kinase, studied using a specific and sensitive peptide assay.
Eur J Biochem
186:
123-128,
1989[ISI][Medline].
6.
Davies, SP,
Sim ATR,
and
Hardie DG.
Location and function of three sites phosphorylated on rat acetyl-CoA carboxylase by the AMP-activated protein kinase.
Eur J Biochem
187:
183-190,
1990[ISI][Medline].
7.
Dean, D,
Daugaard JR,
Young ME,
Saha A,
Vavvas D,
Asp S,
Kiens B,
Kim KH,
Witters L,
Richter EA,
and
Ruderman N.
Exercise diminishes the activity of acetyl-CoA carboxylase in human muscle.
Diabetes
49:
1295-1300,
2000[Abstract].
8.
Derave, W,
Ai H,
Ihlemann J,
Witters LA,
Kristiansen S,
Richter EA,
and
Ploug T.
Dissociation of AMP-activated protein kinase activation and glucose transport in contracting slow-twitch muscle.
Diabetes
49:
1281-1287,
2000[Abstract].
9.
Dudley, GA,
Tullson PC,
and
Terjung RL.
Influence of mitochondrial content on sensitivity of respiratory control.
J Biol Chem
262:
9109-9114,
1987
10.
Dyck, JRB,
Kudo N,
Barr AJ,
Davies SP,
Hardie DG,
and
Lopaschuk GD.
Phosphorylation control of cardiac acetyl-CoA carboxylase by cAMP-dependent protein kinase and 5'-AMP activated protein kinase.
Eur J Biochem
262:
184-190,
1999[ISI][Medline].
11.
Fugii, N,
Hayashi T,
Hirshman MF,
Smith JT,
Habinowski SA,
Kaijser L,
Mu J,
Ljungqvist O,
Birnbaum MJ,
Witters LA,
Thorell A,
and
Goodyear LJ.
Exercise induces isoform-specific increase in 5'AMP-activated protein kinase activity in human skeletal muscle.
Biochem Biophys Res Commun
273:
1150-1155,
2000[ISI][Medline].
12.
Gutman, I,
and
Wahlefeld AW.
L(+) lactate determination with lactate dehydrogenase and NAD.
In: Methods of Enzymatic Analysis, edited by Bergemeyer HU.. New York: Academic, 1974, p. 1464-1468.
13.
Habinowski, SA,
Hirshman M,
Sakamoto K,
Kemp BE,
Gould SJ,
Goodyear LJ,
and
Witters LA.
Malonyl-CoA decarboxylase is not a substrate of AMP-activated protein kinase in rat fast-twitch skeletal muscle or an islet cell line.
Arch Biochem Biophys
396:
71-79,
2001[ISI][Medline].
14.
Ha, J,
Daniel S,
Broyles SS,
and
Kim K-H.
Critical phosphorylation sites for acetyl-CoA carboxylase activity.
J Biol Chem
269:
22162-22168,
1994
15.
Ha, J,
Lee JK,
Kim KS,
and
Witters LA.
Cloning of human acetyl-CoA carboxylase-
and its unique features.
Proc Natl Acad Sci USA
93:
11466-11470,
1996
16.
Hardie, DG,
and
Carling D.
The AMP-activated protein kinase. Fuel gauge of the mammalian cell.
Eur J Biochem
246:
259-273,
1997[ISI][Medline].
17.
Hardie, DG,
Salt IP,
and
Davies SP.
Analysis of the role of the AMP-activated protein kinase in the response to cellular stress.
Methods Mol Biol
99:
63-74,
2000[Medline].
18.
Hawley, SA,
Davison Woods A,
Davies SP,
Beri RK,
Carling D,
and
Hardie DG.
Characterization of the AMP-activated protein kinase kinase from rat liver, and identification of threonine-172 as the major site at which it phosphorylates and activates AMP-activated protein kinase.
J Biol Chem
271:
27879-27887,
1996
19.
Heinz, F,
and
Weisser H.
Creatine phosphate.
In: Methods of Enzymatic Analysis, edited by Bergemeyer HU.. New York: Academic, 1983, p. 507-514.
20.
Hutber, CA,
Hardie DG,
and
Winder WW.
Electrical stimulation inactivates muscle acetyl-CoA carboxylase and increases AMP-activated protein kinase.
Am J Physiol Endocrinol Metab
272:
E262-E266,
1997
21.
Kim, KH,
Lopez-Casillas F,
Bai DH,
Luo X,
and
Pape ME.
Role of reversible phosphorylation of acetyl-CoA carboxylase in long-chain fatty acid synthesis.
FASEB J
3:
2250-2256,
1989[Abstract].
22.
Kudo, N,
Barr AJ,
Barr RL,
Desai S,
and
Lopaschuk GD.
High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5'-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase.
J Biol Chem
270:
17513-17520,
1995
23.
Lopaschuk, GD,
and
Gamble J.
Acetyl-CoA carboxylase: an important regulator of fatty acid oxidation in the heart.
Can J Physiol Pharmacol
72:
1101-1109,
1994[ISI][Medline].
24.
McGarry, JD.
Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes.
Diabetes
51:
7-18,
2002
25.
McGarry, JD,
and
Brown NF.
The mitochondrial carnitine palmitoyltransferase system from concept to molecular analysis.
Eur J Biochem
244:
1-14,
1997[ISI][Medline].
26.
McGarry, JD,
Mills SE,
Long CS,
and
Foster DW.
Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues.
Biochem J
214:
21-28,
1983[ISI][Medline].
27.
Merrill, GF,
Kurth EJ,
Hardie DG,
and
Winder WW.
AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle.
Am J Physiol Endocrinol Metab
273:
E1107-E1112,
1997
28.
Merrill, GF,
Kurth EJ,
Rasmussen BB,
and
Winder WW.
Influence of malonyl-CoA and palmitate concentration on rate of palmitate oxidation in rat muscle.
J Appl Physiol
85:
1909-1914,
1998
29.
Mu, J,
Brozinick JT,
Valladares O,
Bucan M,
and
Birnbaum MJ.
A role for AMP-activated protein kinase in contraction and hypoxia regulated glucose transport in skeletal muscle.
Mol Cell
7:
1085-1094,
2001[ISI][Medline].
30.
Muoio, DM,
Seefeld K,
Witters LA,
and
Coleman RA.
AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target.
Biochem J
338:
783-791,
1999[ISI][Medline].
31.
Musi, N,
Fugii N,
Hirshman MF,
Ekberg I,
Froberg S,
Ljungqvist O,
Thorell A,
and
Goodyear LJ.
AMP-activated protein kinase (AMPK) is activated in muscle of subjects with type 2 diabetes during exercise.
Diabetes
50:
921-927,
2001
32.
Odland, LM,
Heigenhauser GJ,
and
Spriet LL.
Effects of high fat provision on muscle PDH activation and malonyl-CoA content in moderate exercise.
J Appl Physiol
89:
2352-2358,
2000
33.
Odland, LM,
Heigenhauser GJ,
Lopaschuk GD,
and
Spriet LL.
Human skeletal muscle malonyl-CoA at rest and during prolonged submaximal exercise.
Am J Physiol Endocrinol Metab
270:
E541-E544,
1996
34.
Odland, LM,
Howlett RA,
Heigenhauser GJ,
Hultman E,
and
Spriet LL.
Skeletal muscle malonyl-CoA content at the onset of exercise at varying power outputs in humans.
Am J Physiol Endocrinol Metab
274:
E1080-E1085,
1998
35.
Passonneau, JV,
and
Lowry OH.
Enzymatic Analysis: A Practical Guide. Totowa, NJ: Humana, 1993, p. 177-178.
36.
Ponticos, M,
Lu QL,
Morgan JE,
Hardie DG,
Partridge TA,
and
Carling D.
Dual regulation of the AMP-activated protein kinase provides a novel mechanism for the control of creatine kinase in skeletal muscle.
EMBO J
17:
1688-1699,
1998[ISI][Medline].
37.
Rasmussen, BB,
Hancock CR,
and
Winder WW.
Post-exercise recovery of skeletal muscle malonyl-CoA, acetyl-CoA carboxylase, and AMP-activated protein kinase.
J Appl Physiol
85:
1629-1634,
1998
38.
Rasmussen, BB,
and
Winder WW.
Effect of exercise intensity on skeletal muscle malonyl-CoA and acetyl-CoA carboxylase.
J Appl Physiol
83:
1104-1109,
1997
39.
Ruderman, NB,
Saha AK,
Vavvas D,
and
Witters LA.
Malonyl-CoA, fuel sensing, and insulin resistance.
Am J Physiol Endocrinol Metab
276:
E1-E18,
1999
40.
Saha, AK,
Schwarsin AJ,
Roduit R,
Massé F,
Kaushik V,
Tornheim K,
Prentki M,
and
Ruderman NB.
Activation of malonyl-CoA decarboxylase in rat skeletal muscle by contraction and the AMP-activated protein kinase activator aminoimidazole-4-carboxamide-1-
-D-ribofuranoside.
J Biol Chem
275:
24279-24283,
2000
41.
Saddik, M,
Gamble J,
Witters LA,
and
Lopaschuk GD.
Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart.
J Biol Chem
268:
25836-25845,
1993
42.
Saggerson, D,
Ghadiminejad I,
and
Awan M.
Regulation of mitochondrial carnitine palmitoyl transferases from liver and extrahepatic tissues.
Adv Enzyme Regul
32:
285-306,
1992[ISI][Medline].
43.
Stein, SC,
Woods A,
Jones NA,
Davison MD,
and
Carling D.
The regulation of AMP-activated protein kinase by phosphorylation.
Biochem J
345:
437-443,
2000[ISI][Medline].
44.
Stephens, TJ,
Chen ZP,
Canny BJ,
Michell BJ,
Kemp BE,
and
McConell GK.
Progressive increase in human skeletal muscle AMPK
2 activity and ACC phosphorylation during exercise.
Am J Physiol Endocrinol Metab
282:
E688-E694,
2002
45.
Trumble, GE,
Smith MA,
and
Winder WW.
Purification and characterization of rat skeletal muscle acetyl-CoA carboxylase.
Eur J Biochem
231:
192-198,
1995[ISI][Medline].
46.
Vavvas, D,
Apazidis A,
Saha AK,
Gamble J,
Patel A,
Kemp BE,
Witters LA,
and
Ruderman NB.
Contraction-induced changes in acetyl-CoA carboxylase and 5'-AMP-activated kinase in skeletal muscle.
J Biol Chem
272:
13256-13261,
1997.
47.
Verhoeven, AJM,
Woods A,
Brennan CH,
Hawley SA,
Hardie DG,
Scott J,
Beri RK,
and
Carling D.
The AMP-activated protein kinase gene is highly expressed in rat skeletal muscle.
Eur J Biochem
228:
236-243,
1995[ISI][Medline].
48.
Wahlefeld, A,
and
Siedel J.
Creatine and creatinine.
In: Methods of Enzymatic Analysis, edited by Bergemeyer HU.. New York: Academic, 1983, p. 500-507.
49.
Widmer, J,
Fassihi KS,
Schlichter SC,
Wheeler KS,
Crute BE,
King N,
Nutile-McMenemy N,
Noll WW,
Daniel S,
Ha J,
Kim KH,
and
Witters LA.
Identification of a second human acetyl-CoA carboxylase gene.
Biochem J
316:
915-922,
1996[Medline].
50.
Winder, WW.
Energy sensing and signaling by AMP-activated protein kinase in skeletal muscle.
J Appl Physiol
91:
1017-1028,
2001
51.
Winder, WW,
Arogyasami J,
Elayan IM,
and
Cartmill D.
Time course of the exercise-induced decline in malonyl-CoA in different muscle types.
Am J Physiol Endocrinol Metab
259:
E266-E271,
1990
52.
Winder, WW,
and
Hardie DG.
AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes.
Am J Physiol Endocrinol Metab
277:
E1-E10,
1999
53.
Winder, WW,
and
Hardie DG.
Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise.
Am J Physiol Endocrinol Metab
270:
E299-E304,
1996
54.
Winder, WW,
and
Holmes BF.
Insulin stimulation of glucose uptake fails to decrease palmitate oxidation in muscle if AMPK is activated.
J Appl Physiol
89:
2430-2437,
2000
55.
Winder, WW,
Wilson HA,
Hardie DG,
Rasmussen BB,
Hutber CA,
Call GB,
Clayton RD,
Conley LM,
Yoon S,
and
Zhou B.
Phosphorylation of rat muscle acetyl-CoA carboxylase by AMP-activated protein kinase and protein kinase A.
J Appl Physiol
82:
219-225,
1997
56.
Witters, LA,
Widmer J,
King AN,
Fassihi K,
and
Kuhajda F.
Identification of human acetyl-CoA carboxylase isozymes in tissue and in breast cancer cells.
Int J Biochem
26:
589-594,
1994[ISI][Medline].
57.
Wojtaszewski, JF,
Nielsen P,
Hansen BF,
Richter EA,
and
Kiens B.
Isoform-specific and exercise intensity-dependent activation of 5'-AMP-activated protein kinase in human skeletal muscle.
J Physiol
528:
221-226,
2000
This article has been cited by other articles:
![]() |
D. M. Thomson, C. A. Fick, and S. E. Gordon AMPK activation attenuates S6K1, 4E-BP1, and eEF2 signaling responses to high-frequency electrically stimulated skeletal muscle contractions J Appl Physiol, March 1, 2008; 104(3): 625 - 632. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Rantzau, M. Christopher, and F. P. Alford Contrasting effects of exercise, AICAR, and increased fatty acid supply on in vivo and skeletal muscle glucose metabolism J Appl Physiol, February 1, 2008; 104(2): 363 - 370. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Irrcher, D. R. Walkinshaw, T. E. Sheehan, and D. A. Hood Thyroid hormone (T3) rapidly activates p38 and AMPK in skeletal muscle in vivo J Appl Physiol, January 1, 2008; 104(1): 178 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Ross, G. D. Wadley, M. G. Clark, S. Rattigan, and G. K. McConell Local Nitric Oxide Synthase Inhibition Reduces Skeletal Muscle Glucose Uptake but Not Capillary Blood Flow During In Situ Muscle Contraction in Rats Diabetes, December 1, 2007; 56(12): 2885 - 2892. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. LaRosa and S. M. Downs Meiotic Induction by Heat Stress in Mouse Oocytes: Involvement of AMP-Activated Protein Kinase and MAPK Family Members Biol Reprod, March 1, 2007; 76(3): 476 - 486. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Ellingson, D. G. Chesser, and W. W. Winder Effects of 3-phosphoglycerate and other metabolites on the activation of AMP-activated protein kinase by LKB1-STRAD-MO25 Am J Physiol Endocrinol Metab, February 1, 2007; 292(2): E400 - E407. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Suwa, T. Egashira, H. Nakano, H. Sasaki, and S. Kumagai Metformin increases the PGC-1{alpha} protein and oxidative enzyme activities possibly via AMPK phosphorylation in skeletal muscle in vivo J Appl Physiol, December 1, 2006; 101(6): 1685 - 1692. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Raney and L. P. Turcotte Regulation of contraction-induced FA uptake and oxidation by AMPK and ERK1/2 is intensity dependent in rodent muscle Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1220 - E1227. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Christopher, C. Rantzau, Z.-P. Chen, R. Snow, B. Kemp, and F. P. Alford Impact of in vivo fatty acid oxidation blockade on glucose turnover and muscle glucose metabolism during low-dose AICAR infusion Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E1131 - E1140. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Jaswal, M. Gandhi, B. A. Finegan, J. R. B. Dyck, and A. S. Clanachan Effects of adenosine on myocardial glucose and palmitate metabolism after transient ischemia: role of 5'-AMP-activated protein kinase Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1883 - H1892. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Fosgerau, C. Fledelius, K. E Pedersen, J. B Kristensen, J. R Daugaard, M. A Iglesias, E. W Kraegen, and S. M Furler Oral administration of glucose promotes intracellular partitioning of fatty acid toward storage in white but not in red muscle. J. Endocrinol., September 1, 2006; 190(3): 651 - 658. [Abstract] [Full Text] [PDF] |
||||
![]() |